+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
DNA Fragments Market by Type, Product Type, Application, End-User - Global Forecast to 2030- Product Image
DNA Fragments Market by Type, Product Type, Application, End-User - Global Forecast to 2030- Product Image
Sale

DNA Fragments Market by Type, Product Type, Application, End-User - Global Forecast to 2030

  • PDF Icon

    Report

  • 184 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6084025
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The DNA Fragments Market grew from USD 2.06 billion in 2024 to USD 2.23 billion in 2025. It is expected to continue growing at a CAGR of 8.18%, reaching USD 3.31 billion by 2030.

Exploring the Evolving Landscape of DNA Fragmentation

The global market for DNA fragments has entered an era of unprecedented expansion, propelled by rapid technological progress and escalating demand across diverse industries. In the wake of gene editing breakthroughs and the proliferation of personalized medicine, DNA fragments have emerged as indispensable building blocks for molecular diagnostics, therapeutic developments, and advanced research applications. As laboratories worldwide intensify their focus on accelerating discovery timelines, fragmentation techniques are evolving to deliver greater precision, reproducibility, and cost efficiency. These developments are reshaping traditional workflows and enabling novel applications that were once beyond reach.

As we embark on this executive summary, this introduction establishes the foundational context for understanding key market drivers, dynamic legislative factors, and evolving competitive landscapes. By examining critical trends and regulatory influences, we lay the groundwork for deeper analysis in subsequent sections. Stakeholders will gain clarity on how disruptive innovations and external pressures converge to create new pockets of opportunity, setting the stage for informed strategic planning and robust portfolio optimization.

Emerging Forces Redefining DNA Fragment Applications

Over the past five years, the DNA fragment arena has experienced transformative shifts driven by technological breakthroughs and changing research priorities. Advances in enzymatic cleavage methodologies now enable unprecedented control over fragment length and sequence fidelity, which has accelerated applications in synthetic biology and gene therapy. Concurrently, integration of automation and artificial intelligence in fragment analysis has streamlined workflows, reducing manual intervention and enhancing reproducibility across high-throughput platforms.

Meanwhile, emerging alliances between academic institutions and biotech firms have fostered cross-disciplinary innovation, bridging gaps between computational biology and wet-lab experimentation. This synergy has accelerated time-to-market for novel assays and diagnostic kits that rely on precisely defined DNA fragments. Furthermore, the convergence of open-source platforms and proprietary pipelines is democratizing access to cutting-edge fragmentation tools, enabling a broader range of end-users to participate in advanced genomics research. As a result, traditional vendor-centric models are giving way to collaborative ecosystems that prioritize interoperability, scalability, and rapid iteration.

Assessing the 2025 US Tariff Implications for DNA Fragment Trade

The imposition of new U.S. tariffs effective in 2025 is poised to reverberate throughout the global DNA fragment supply chain, altering cost structures and sourcing strategies. Manufacturers of both custom and synthetic fragments are assessing the impact of import duties on critical reagents and raw materials, including specialized enzymes and nucleotides. These adjustments are prompting shifts in procurement, as stakeholders seek to mitigate elevated expenses through regional manufacturing or dual-sourcing arrangements.

In response, some fragment providers have accelerated efforts to localize production facilities within North America, aiming to offset tariff penalties and maintain price competitiveness for domestic end-users. At the same time, downstream users in diagnostics and therapeutics are reexamining project budgets to accommodate potential cost escalations. Despite these challenges, the tariff landscape also presents impetus for innovation, encouraging suppliers to explore alternative enzyme systems and cost-efficient synthesis platforms. As the market adapts, collaborative initiatives among suppliers, distributors, and research organizations will be critical to sustaining momentum and overcoming trade-related constraints.

Unveiling Market Dynamics Through Segmentation Analysis

The DNA fragment market’s architecture is defined by diverse segmentation parameters that shape demand patterns and innovation trajectories. At the core, strand structure delineation distinguishes double-stranded fragments from their single-stranded counterparts, each catering to unique assay requirements and stability profiles. Meanwhile, the bifurcation of product offerings into custom DNA and synthetic DNA drives specialization, with custom solutions tailored through gene synthesis and fragment design, and synthetic variants produced as long or short oligonucleotides to serve varied throughput and cost targets.

Application-based differentiation further refines market dynamics, as biotechnology firms leverage bioinformatics-enhanced fragments to construct complex genetic circuits, while diagnostics developers utilize targeted fragment sets in companion testing. Research and development environments demand broad versatility, spanning exploratory fragment libraries to precise therapeutic constructs. Finally, the end-user landscape encompasses academic and research institutes pioneering foundational studies, hospitals and clinics integrating diagnostic assays into patient care, and pharmaceutical companies scaling fragment-based platforms for drug discovery. Collectively, these segmentation dimensions underscore the intricate interplay between technical specifications and end-user expectations, illuminating pathways for tailored product innovation and strategic investment.

Regional Performance Highlights Across Global Markets

Geographical performance patterns reveal nuanced strengths and emerging opportunities in the DNA fragment arena. The Americas maintain a formidable presence, underpinned by advanced research infrastructure, robust funding for life sciences, and a concentration of leading fragment service providers. This region’s maturity supports high-volume demand across clinical diagnostics and biopharmaceutical pipelines, while recent regulatory reforms are catalyzing streamlined approvals for fragment-based assays.

In Europe, the Middle East & Africa, diverse regulatory environments and varied investment landscapes characterise regional dynamics. Western Europe’s established genomics hubs continue to drive innovation in fragment technologies, supported by collaborative consortia and public-private partnerships. In contrast, emerging markets in the Middle East & Africa present untapped potential, where governmental initiatives aim to bolster biotech capabilities and localize production.

Meanwhile, Asia-Pacific stands out for its rapid capacity expansion, fueled by substantial R&D investment from both government and private sectors. Commercial fragment synthesis facilities are scaling operations to meet domestic demand, particularly in China, Japan, and India, while cross-border collaborations are forging new channels for technology transfer and market entry. Overall, these regional insights highlight the importance of adaptive go-to-market strategies that align with localized regulatory requirements, funding frameworks, and innovation ecosystems.

Profiles of Leading DNA Fragment Innovators

A cadre of leading providers continues to shape the competitive landscape of DNA fragments through strategic investments and pipeline expansions. Industry frontrunners have leveraged proprietary synthesis platforms to enhance fragment fidelity, reduce lead times, and customize offerings across a spectrum of research and clinical applications. This focus on technological differentiation is reinforced by targeted acquisitions, as companies consolidate complementary capabilities in enzyme engineering and automated purification.

Emerging entrants, meanwhile, are carving niche positions by specializing in high-throughput oligonucleotide production and offering modular, API-driven ordering interfaces that cater to digitally native laboratories. Partnerships with software developers have further enabled real-time monitoring of fragment quality metrics, fostering transparency and traceability throughout the supply chain. As competition intensifies, collaboration between established players and agile startups is accelerating the introduction of hybrid service models that blend custom gene synthesis with on-demand fragment libraries. These evolving competitive dynamics underscore the dual imperatives of scale and specialization for sustaining leadership in the global DNA fragment market.

Strategic Imperatives for Competitive Advantage

To remain at the cutting edge of the DNA fragment market, industry leaders must pursue a combination of technological agility and strategic foresight. First, investing in platform automation and integrating machine learning for quality control can elevate production consistency and accelerate turnaround times. Second, forging regional partnerships and establishing localized manufacturing hubs will mitigate trade-related risks and ensure supply chain resilience in the face of evolving tariff regimes. Third, expanding service portfolios to encompass end-to-end support-from fragment design consulting to post-synthesis verification-will enhance value delivery and deepen customer engagement.

Furthermore, proactive engagement with regulatory bodies and participation in standardization initiatives will facilitate timely approvals and foster industry-wide best practices. Finally, cultivating collaborative ecosystems that bring together academic, clinical, and industrial stakeholders can unlock new application avenues and drive market growth. By adopting these strategic imperatives, decision-makers can secure sustainable competitive advantage and position their organizations to capitalize on the accelerating demand for DNA fragment technologies.

Robust Framework Underpinning the Research Approach

This research draws upon a multi-layered methodology designed to ensure robust, objective, and actionable insights. Primary research comprised in-depth interviews with senior executives, laboratory directors, and procurement managers across biotechnology, medical diagnostics, and academic research institutions. These qualitative interactions were complemented by quantitative surveys administered to a broad cross-section of end-users, capturing purchasing behaviors, pricing sensitivities, and technology adoption patterns.

Secondary research involved systematic analysis of industry publications, regulatory filings, and financial reports from leading fragment providers. Patent databases and scientific literature were reviewed to track innovation trajectories and emerging synthesis techniques. Market intelligence was further refined through competitive benchmarking and performance analysis of key players. Data triangulation methodologies were employed throughout to validate findings and reconcile discrepancies between primary and secondary sources. Ethical considerations and data confidentiality protocols were rigorously maintained, ensuring the integrity and credibility of the final insights presented in this report.

Synthesis of Insights for Strategic Decision-Making

Through comprehensive analysis of technological trends, tariff influences, segmentation dynamics, regional performance, and competitive strategies, this executive summary synthesizes essential insights to guide strategic decision-making. The accelerating demand for both custom and synthetic DNA fragments underscores the criticality of agile manufacturing capabilities and precision in fragment design. Navigating the evolving U.S. tariff landscape will require adaptive supply chain strategies and investments in localized production.

Furthermore, segmentation analysis reveals diverse end-user requirements that necessitate tailored product offerings, while regional insights highlight the importance of localized regulatory and funding environments. Leading companies are differentiating through platform innovation and strategic collaborations, setting benchmarks for operational excellence. Ultimately, industry stakeholders who embrace data-driven decision-making, foster cross-sector partnerships, and invest in next-generation synthesis technologies will be best positioned to drive growth and innovation in the DNA fragment market.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Type
    • Double-Stranded
    • Single-Stranded
  • Product Type
    • Custom DNA
      • Custom Gene Synthesis
      • Gene Fragments
    • Synthetic DNA
      • Long Oligos
      • Short Oligos
  • Application
    • Biotechnology
      • Bioinformatics
      • Biotechnology
    • Medical
      • Diagnostics
      • Therapeutics
    • Research & Development
  • End-User
    • Academic & Research Institutes
    • Hospitals & Clinics
    • Pharmaceutical Companies
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Ansa Biotechnologies, Inc.
  • Azenta Life Sciences
  • BioVision Inc.
  • DNA TwoPointO Inc.
  • Eurofins Scientific SE
  • Gene Universal, Inc.
  • GenScript Biotech Corporation
  • Illumina, Inc.
  • Integrated DNA Technologies, Inc. by Danaher Corporation
  • Merck KGaA
  • Meridian Bioscience, Inc.
  • Novartis AG
  • Pacific Biosciences of California, Inc.
  • QIAGEN N.V
  • Synbio Technologies LLC
  • Takara Bio USA, Inc.
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience Corporation

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. DNA Fragments Market, by Type
8.1. Introduction
8.2. Double-Stranded
8.3. Single-Stranded
9. DNA Fragments Market, by Product Type
9.1. Introduction
9.2. Custom DNA
9.2.1. Custom Gene Synthesis
9.2.2. Gene Fragments
9.3. Synthetic DNA
9.3.1. Long Oligos
9.3.2. Short Oligos
10. DNA Fragments Market, by Application
10.1. Introduction
10.2. Biotechnology
10.2.1. Bioinformatics
10.2.2. Biotechnology
10.3. Medical
10.3.1. Diagnostics
10.3.2. Therapeutics
10.4. Research & Development
11. DNA Fragments Market, by End-User
11.1. Introduction
11.2. Academic & Research Institutes
11.3. Hospitals & Clinics
11.4. Pharmaceutical Companies
12. Americas DNA Fragments Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa DNA Fragments Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific DNA Fragments Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Abbott Laboratories
15.3.2. Agilent Technologies, Inc.
15.3.3. Ansa Biotechnologies, Inc.
15.3.4. Azenta Life Sciences
15.3.5. BioVision Inc.
15.3.6. DNA TwoPointO Inc.
15.3.7. Eurofins Scientific SE
15.3.8. Gene Universal, Inc.
15.3.9. GenScript Biotech Corporation
15.3.10. Illumina, Inc.
15.3.11. Integrated DNA Technologies, Inc. by Danaher Corporation
15.3.12. Merck KGaA
15.3.13. Meridian Bioscience, Inc.
15.3.14. Novartis AG
15.3.15. Pacific Biosciences of California, Inc.
15.3.16. QIAGEN N.V
15.3.17. Synbio Technologies LLC
15.3.18. Takara Bio USA, Inc.
15.3.19. Thermo Fisher Scientific Inc.
15.3.20. Twist Bioscience Corporation
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. DNA FRAGMENTS MARKET MULTI-CURRENCY
FIGURE 2. DNA FRAGMENTS MARKET MULTI-LANGUAGE
FIGURE 3. DNA FRAGMENTS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL DNA FRAGMENTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL DNA FRAGMENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DNA FRAGMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DNA FRAGMENTS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DNA FRAGMENTS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DNA FRAGMENTS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DNA FRAGMENTS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS DNA FRAGMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS DNA FRAGMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC DNA FRAGMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC DNA FRAGMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. DNA FRAGMENTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. DNA FRAGMENTS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. DNA FRAGMENTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DNA FRAGMENTS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DNA FRAGMENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DNA FRAGMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL DNA FRAGMENTS MARKET SIZE, BY DOUBLE-STRANDED, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DNA FRAGMENTS MARKET SIZE, BY SINGLE-STRANDED, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DNA FRAGMENTS MARKET SIZE, BY CUSTOM GENE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DNA FRAGMENTS MARKET SIZE, BY GENE FRAGMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DNA FRAGMENTS MARKET SIZE, BY LONG OLIGOS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DNA FRAGMENTS MARKET SIZE, BY SHORT OLIGOS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DNA FRAGMENTS MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DNA FRAGMENTS MARKET SIZE, BY MEDICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DNA FRAGMENTS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DNA FRAGMENTS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DNA FRAGMENTS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL DNA FRAGMENTS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL DNA FRAGMENTS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL DNA FRAGMENTS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS DNA FRAGMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 50. CANADA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 51. CANADA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 52. CANADA DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
TABLE 53. CANADA DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
TABLE 54. CANADA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. CANADA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 56. CANADA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 57. CANADA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 58. MEXICO DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 59. MEXICO DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 60. MEXICO DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
TABLE 61. MEXICO DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
TABLE 62. MEXICO DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. MEXICO DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 64. MEXICO DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 65. MEXICO DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 91. UNITED KINGDOM DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. UNITED KINGDOM DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 93. UNITED KINGDOM DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
TABLE 94. UNITED KINGDOM DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
TABLE 95. UNITED KINGDOM DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. UNITED KINGDOM DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. GERMANY DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. GERMANY DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 101. GERMANY DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
TABLE 102. GERMANY DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
TABLE 103. GERMANY DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. GERMANY DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 105. GERMANY DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 106. GERMANY DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 107. FRANCE DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 108. FRANCE DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 109. FRANCE DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
TABLE 110. FRANCE DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
TABLE 111. FRANCE DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. FRANCE DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 113. FRANCE DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 114. FRANCE DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. RUSSIA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 116. RUSSIA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 123. ITALY DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 124. ITALY DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 125. ITALY DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
TABLE 126. ITALY DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
TABLE 127. ITALY DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. ITALY DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 129. ITALY DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 130. ITALY DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 131. SPAIN DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 132. SPAIN DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 133. SPAIN DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
TABLE 134. SPAIN DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
TABLE 135. SPAIN DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. SPAIN DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 137. SPAIN DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 138. SPAIN DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. UNITED ARAB EMIRATES DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 145. UNITED ARAB EMIRATES DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 146. UNITED ARAB EMIRATES DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 147. SAUDI ARABIA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 148. SAUDI ARABIA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 149. SAUDI ARABIA DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
TABLE 150. SAUDI ARABIA DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
TABLE 151. SAUDI ARABIA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. SAUDI ARABIA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 153. SAUDI ARABIA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 154. SAUDI ARABIA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 155. SOUTH AFRICA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 156. SOUTH AFRICA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 157. SOUTH AFRICA DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
TABLE 158. SOUTH AFRICA DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
TABLE 159. SOUTH AFRICA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 163. DENMARK DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 164. DENMARK DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 165. DENMARK DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
TABLE 166. DENMARK DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
TABLE 167. DENMARK DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. DENMARK DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 169. DENMARK DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 170. DENMARK DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 171. NETHERLANDS DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 172. NETHERLANDS DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 173. NETHERLANDS DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
TABLE 174. NETHERLANDS DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
TABLE 175. NETHERLANDS DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. NETHERLANDS DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 177. NETHERLANDS DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 178. NETHERLANDS DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 179. QATAR DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 180. QATAR DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 181. QATAR DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
TABLE 182. QATAR DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
TABLE 183. QATAR DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. QATAR DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 185. QATAR DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 186. QATAR DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 187. FINLAND DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 188. FINLAND DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 189. FINLAND DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
TABLE 190. FINLAND DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
TABLE 191. FINLAND DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 192. FINLAND DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 193. FINLAND DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 194. FINLAND DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 195. SWEDEN DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 196. SWEDEN DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 197. SWEDEN DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
TABLE 198. SWEDEN DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
TABLE 199. SWEDEN DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 200. SWEDEN DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 201. SWEDEN DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 202. SWEDEN DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 203. NIGERIA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 204. NIGERIA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 205. NIGERIA DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
TABLE 206. NIGERIA DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
TABLE 207. NIGERIA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. NIGERIA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 211. EGYPT DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 212. EGYPT DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 213. EGYPT DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
TABLE 214. EGYPT DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
TABLE 215. EGYPT DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 216. EGYPT DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 217. EGYPT DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 218. EGYPT DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 219. TURKEY DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 220. TURKEY DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 221. TURKEY DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
TABLE 222. TURKEY DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
TABLE 223. TURKEY DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 224. TURKEY DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 225. TURKEY DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 226. TURKEY DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 227. ISRAEL DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 228. ISRAEL DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 229. ISRAEL DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
TABLE 230. ISRAEL DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
TABLE 231. ISRAEL DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 232. ISRAEL DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 233. ISRAEL DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 234. ISRAEL DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 235. NORWAY DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 236. NORWAY DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 237. NORWAY DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
TABLE 238. NORWAY DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
TABLE 239. NORWAY DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 240. NORWAY DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 241. NORWAY DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 242. NORWAY DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 243. POLAND DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 244. POLAND DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 245. POLAND DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
TABLE 246. POLAND DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
TABLE 247. POLAND DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 248. POLAND DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 249. POLAND DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 250. POLAND DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 251. SWITZERLAND DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 252. SWITZERLAND DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 253. SWITZERLAND DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
TABLE 254. SWITZERLAND DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
TABLE 255. SWITZERLAND DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 259. ASIA-PACIFIC DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 260. ASIA-PACIFIC DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 261. ASIA-PACIFIC DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
TABLE 262. ASIA-PACIFIC DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
TABLE 263. ASIA-PACIFIC DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 264. ASIA-PACIFIC DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 265. ASIA-PACIFIC DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 266. ASIA-PACIFIC DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC DNA FRAGMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 268. CHINA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 269. CHINA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 270. CHINA DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
TABLE 271. CHINA DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
TABLE 272. CHINA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 273. CHINA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 274. CHINA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 275. CHINA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 276. INDIA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 277. INDIA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 278. INDIA DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
TABLE 279. INDIA DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
TABLE 280. INDIA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 281. INDIA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 282. INDIA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 283. INDIA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 284. JAPAN DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 285. JAPAN DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 286. JAPAN DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
TABLE 287. JAPAN DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
TABLE 288. JAPAN DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 289. JAPAN DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 290. JAPAN DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 291. JAPAN DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 292. AUSTRALIA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 293. AUSTRALIA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 294. AUSTRALIA DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
TABLE 295. AUSTRALIA DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
TABLE 296. AUSTRALIA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 297. AUSTRALIA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 298. AUSTRALIA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 299. AUSTRALIA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 300. SOUTH KOREA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 301. SOUTH KOREA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 302. SOUTH KOREA DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
TABLE 303. SOUTH KOREA DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
TABLE 304. SOUTH KOREA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 305. SOUTH KOREA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 306. SOUTH KOREA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 307. SOUTH KOREA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 308. INDONESIA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 309. INDONESIA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 310. INDONESIA DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
TABLE 311. INDONESIA DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
TABLE 312. INDONESIA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 313. INDONESIA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 314. INDONESIA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 315. INDONESIA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 316. THAILAND DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 317. THAILAND DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 318. THAILAND DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
TABLE 319. THAILAND DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
TABLE 320. THAILAND DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 321. THAILAND DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 322. THAILAND DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 323. THAILAND DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 324. PHILIPPINES DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 325. PHILIPPINES DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 326. PHILIPPINES DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
TABLE 327. PHILIPPINES DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
TABLE 328. PHILIPPINES DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 329. PHILIPPINES DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 330. PHILIPPINES DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 331. PHILIPPINES DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 332. MALAYSIA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 333. MALAYSIA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 334. MALAYSIA DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
TABLE 335. MALAYSIA DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
TABLE 336. MALAYSIA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 337. MALAYSIA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 338. MALAYSIA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 339. MALAYSIA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 340. SINGAPORE DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 341. SINGAPORE DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 342. SINGAPORE DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
TABLE 343. SINGAPORE DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
TABLE 344. SINGAPORE DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 345. SINGAPORE DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 346. SINGAPORE DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 347. SINGAPORE DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 348. VIETNAM DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 349. VIETNAM DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 350. VIETNAM DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
TABLE 351. VIETNAM DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
TABLE 352. VIETNAM DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 353. VIETNAM DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 354. VIETNAM DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 355. VIETNAM DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 356. TAIWAN DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 357. TAIWAN DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 358. TAIWAN DNA FRAGMENTS MARKET SIZE, BY CUSTOM DNA, 2018-2030 (USD MILLION)
TABLE 359. TAIWAN DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, 2018-2030 (USD MILLION)
TABLE 360. TAIWAN DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 361. TAIWAN DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 362. TAIWAN DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 363. TAIWAN DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 364. DNA FRAGMENTS MARKET SHARE, BY KEY PLAYER, 2024
TABLE 365. DNA FRAGMENTS MARKET, FPNV POSITIONING MATRIX, 2024

Companies Mentioned

The companies profiled in this DNA Fragments market report include:
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Ansa Biotechnologies, Inc.
  • Azenta Life Sciences
  • BioVision Inc.
  • DNA TwoPointO Inc.
  • Eurofins Scientific SE
  • Gene Universal, Inc.
  • GenScript Biotech Corporation
  • Illumina, Inc.
  • Integrated DNA Technologies, Inc. by Danaher Corporation
  • Merck KGaA
  • Meridian Bioscience, Inc.
  • Novartis AG
  • Pacific Biosciences of California, Inc.
  • QIAGEN N.V
  • Synbio Technologies LLC
  • Takara Bio USA, Inc.
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience Corporation

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages184
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.23 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.31 Billion
Compound Annual Growth Rate8.1%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Custom Synthetic Genes Services Market by Technology, Product, End User, Application, Gene Type - Global Forecast to 2030 - Product Image

Custom Synthetic Genes Services Market by Technology, Product, End User, Application, Gene Type - Global Forecast to 2030

  • Report
  • 182 Pages
  • Global
From
DNA Synthesis Market Size, Share & Trends Analysis Report by Service Type (Gene Synthesis, Oligonucleotide Synthesis), Length, Application (Research Development, Diagnostics), End-use, Region, and Segment Forecasts, 2024-2030 - Product Image

DNA Synthesis Market Size, Share & Trends Analysis Report by Service Type (Gene Synthesis, Oligonucleotide Synthesis), Length, Application (Research Development, Diagnostics), End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 120 Pages
  • Global
From
Blood Relationship Testing Service Market by Application, Test Type, Technology, Sample Type, End User, Distribution Channel - Global Forecast to 2030 - Product Image

Blood Relationship Testing Service Market by Application, Test Type, Technology, Sample Type, End User, Distribution Channel - Global Forecast to 2030

  • Report
  • 189 Pages
  • Global
From
DNA Analysis in The Government Sector Market 2025-2033 - Product Image

DNA Analysis in The Government Sector Market 2025-2033

  • Report
  • 143 Pages
  • Global
From
Capillary Electrophoresis Market Size, Share & Trends Analysis Report By Product (Instruments, Consumable, Software), By Mode, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Capillary Electrophoresis Market Size, Share & Trends Analysis Report By Product (Instruments, Consumable, Software), By Mode, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.